Page last updated: 2024-08-24

rubitecan and Cancer of Prostate

rubitecan has been researched along with Cancer of Prostate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braastad, CD; Chatterjee, D; Darnowski, J; Goldman, M; Goodglick, L; Pantazis, P; Wyche, JH1
Chatterjee, D; Pantazis, P; Wyche, JH1
Chatterjee, D; DeJesus, A; Early, J; Giovanella, B; Pantazis, P; Plaschke, S; Wyche, J1
Chatterjee, D; Kirchhoff, S; Krammer, PH; Krueger, A; Pantazis, P; Peter, ME; Schmitz, I; Wyche, JH; Yeung, K1

Other Studies

4 other study(ies) available for rubitecan and Cancer of Prostate

ArticleYear
Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta.
    International journal of oncology, 2004, Volume: 25, Issue:2

    Topics: 14-3-3 Proteins; Antineoplastic Agents; Apoptosis; Camptothecin; Caspase 3; Caspases; Cloning, Molecular; Drug Resistance, Neoplasm; Gene Expression; Humans; Male; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Transfection; Tumor Cells, Cultured

2004
Induction of apoptosis in malignant and camptothecin-resistant human cells.
    Annals of the New York Academy of Sciences, 1996, Dec-13, Volume: 803

    Topics: Androgens; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Camptothecin; Cell Cycle; Cell Cycle Proteins; DNA Topoisomerases, Type I; Drug Interactions; Drug Resistance; Enzyme Inhibitors; Etoposide; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Suramin; Tumor Cells, Cultured

1996
Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
    Journal of experimental therapeutics & oncology, 1996, Volume: 1, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Camptothecin; Cell Cycle; Flow Cytometry; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured

1996
Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Cancer research, 2001, Oct-01, Volume: 61, Issue:19

    Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 7; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Down-Regulation; Enzyme Activation; Enzyme Precursors; Fas Ligand Protein; fas Receptor; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Glycoproteins; Prostatic Neoplasms; Transfection; Tumor Cells, Cultured

2001